Canaccord Genuity Reiterates a 'Hold' on AspenBio Pharma (APPY); Clinical Timelines Updated
Tweet
Share
E-mailGet Alerts APPY Hot Sheet
Price: $3.94 --0%
Rating Summary:
0 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Rating Summary:
0 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Join SI Premium – FREE
Canaccord Genuity reiterates a 'Hold' on AspenBio Pharma (NASDAQ: APPY), $0.50 PT.
Canaccord analyst, Jeffrey Frelick, said, "We maintain our rating on APPY at this time as we await data from an internal validation study on the AppyScore rapid test. We believe AspenBio Pharma could benefit from a large market opportunity by introducing the first diagnostic test for appendicitis."
For more ratings news on AspenBio Pharma click here and for the rating history of AspenBio Pharma click here.
Shares of AspenBio Pharma closed at $0.66 yesterday.
Canaccord analyst, Jeffrey Frelick, said, "We maintain our rating on APPY at this time as we await data from an internal validation study on the AppyScore rapid test. We believe AspenBio Pharma could benefit from a large market opportunity by introducing the first diagnostic test for appendicitis."
For more ratings news on AspenBio Pharma click here and for the rating history of AspenBio Pharma click here.
Shares of AspenBio Pharma closed at $0.66 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Broker Upgrades John B. Sanfilippo & Son, Inc. (JBSS) to Buy
- NetEase.com (NTES) PT Lowered to $143 at Macquarie
- Seaport Global Securities Upgrades Analog Devices (ADI) to Buy, 'appears to be entering the sweet part of the cycle'
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
